These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes. Han Y; Jing Q; Xu B; Yang L; Liu H; Shang X; Jiang T; Li Z; Zhang H; Li H; Qiu J; Liu Y; Li Y; Chen X; Gao R; JACC Cardiovasc Interv; 2009 Apr; 2(4):303-9. PubMed ID: 19463441 [TBL] [Abstract][Full Text] [Related]
23. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327 [TBL] [Abstract][Full Text] [Related]
24. Choice of stenting strategy in true coronary artery bifurcation lesions. Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498 [TBL] [Abstract][Full Text] [Related]
28. Impairment factors for evaluating the patency of drug-eluting stents and bare metal stents in coronary arteries by 64-slice computed tomography versus conventional coronary angiography. Nakamura K; Funabashi N; Uehara M; Suzuki K; Terao M; Okubo K; Mita Y; Maeda F; Komuro I Int J Cardiol; 2008 Nov; 130(3):349-56. PubMed ID: 18180050 [TBL] [Abstract][Full Text] [Related]
29. In vivo evaluation of stent patency by 64-slice multidetector CT coronary angiography: shall we do it or not? Zhang J; Li M; Lu Z; Hang J; Pan J; Sun L Int J Cardiovasc Imaging; 2012 Mar; 28(3):651-8. PubMed ID: 21461883 [TBL] [Abstract][Full Text] [Related]
30. Computed tomography angiography and myocardial computed tomography perfusion in patients with coronary stents: prospective intraindividual comparison with conventional coronary angiography. Rief M; Zimmermann E; Stenzel F; Martus P; Stangl K; Greupner J; Knebel F; Kranz A; Schlattmann P; Laule M; Dewey M J Am Coll Cardiol; 2013 Oct; 62(16):1476-85. PubMed ID: 23792193 [TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomography findings in lesions after sirolimus-eluting stent implantation with peri-stent contrast staining. Tada T; Kadota K; Hosogi S; Kubo S; Ozaki M; Yoshino M; Miyake K; Eguchi H; Ohashi N; Hayakawa Y; Saito N; Otsuru S; Hasegawa D; Shigemoto Y; Habara S; Imai M; Tanaka H; Fuku Y; Oka N; Kato H; Yamamoto H; Fujii S; Goto T; Mitsudo K Circ Cardiovasc Interv; 2012 Oct; 5(5):649-56. PubMed ID: 23011265 [TBL] [Abstract][Full Text] [Related]
32. Applications of multislice coronary computed tomographic angiography to percutaneous coronary intervention: how did we ever do without it? Hecht HS Catheter Cardiovasc Interv; 2008 Mar; 71(4):490-503. PubMed ID: 18307228 [TBL] [Abstract][Full Text] [Related]
33. New quantitative method to diagnose coronary in-stent restenosis by 64-multislice computed tomography. Yoshimura M; Nao T; Miura T; Okada M; Nakashima Y; Fujimura T; Okamura T; Yamada J; Matsunaga N; Matsuzaki M; Yano M J Cardiol; 2015 Jan; 65(1):57-62. PubMed ID: 24846389 [TBL] [Abstract][Full Text] [Related]
34. Bare metal stent thrombosis 13 years after implantation. Sarkees ML; Bavry AA; Galla JM; Bhatt DL Cardiovasc Revasc Med; 2009; 10(1):58-9. PubMed ID: 19159857 [TBL] [Abstract][Full Text] [Related]
35. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent). Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C; J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457 [TBL] [Abstract][Full Text] [Related]
36. 1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. Klomp M; Beijk MA; Varma C; Koolen JJ; Teiger E; Richardt G; Bea F; van Geloven N; Verouden NJ; Chan YK; Woudstra P; Damman P; Tijssen JG; de Winter RJ JACC Cardiovasc Interv; 2011 Aug; 4(8):896-904. PubMed ID: 21851905 [TBL] [Abstract][Full Text] [Related]
37. Three-dimensional modeling of double-stent techniques at the left main coronary artery bifurcation using micro-focus X-ray computed tomography. Murasato Y; Horiuchi M; Otsuji Y Catheter Cardiovasc Interv; 2007 Aug; 70(2):211-20. PubMed ID: 17421017 [TBL] [Abstract][Full Text] [Related]
38. Dual-source CT angiography for detection and quantification of in-stent restenosis in the left main coronary artery: comparison with intracoronary ultrasound and coronary angiography. Veselka J; Cadova P; Tomasov P; Theodor A; Zemanek D J Invasive Cardiol; 2011 Nov; 23(11):460-4. PubMed ID: 22045078 [TBL] [Abstract][Full Text] [Related]
39. Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice. Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Pichard AD; Waksman R Arch Cardiovasc Dis; 2009 Feb; 102(2):143-51. PubMed ID: 19303582 [TBL] [Abstract][Full Text] [Related]
40. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Lee MS; Jurewitz D; Aragon J; Forrester J; Makkar RR; Kar S Catheter Cardiovasc Interv; 2007 Feb; 69(3):387-94. PubMed ID: 17195203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]